Manulife (Manufacturers Life Insurance)
CYTK icon

Manulife (Manufacturers Life Insurance)’s Cytokinetics CYTK Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11M Sell
167,124
-23,683
-12% -$1.51M 0.01% 814
2025
Q4 		$12M Sell
190,807
-1,090
-0.6% -$67.8K 0.01% 798
2025
Q3 		$10.5M Buy
191,897
+16,618
+9% +$685K 0.01% 837
2025
Q2 		$5.79M Buy
175,279
+7,595
+5% +$264K 0.01% 1099
2025
Q1 		$6.74M Sell
167,684
-20,854
-11% -$958K 0.01% 1020
2024
Q4 		$8.87M Sell
188,538
-26,294
-12% -$1.37M 0.01% 945
2024
Q3 		$11.3M Buy
214,832
+41,057
+24% +$2.29M 0.01% 836
2024
Q2 		$9.42M Buy
173,775
+20,206
+13% +$1.22M 0.01% 861
2024
Q1 		$10.8M Buy
153,569
+54,159
+54% +$4.19M 0.01% 822
2023
Q4 		$8.3M Buy
99,410
+32,852
+49% +$1.19M 0.01% 929
2023
Q3 		$1.96M Sell
66,558
-2,549
-4% -$84.9K ﹤0.01% 1440
2023
Q2 		$2.25M Buy
69,107
+4,178
+6% +$155K ﹤0.01% 1383
2023
Q1 		$2.28M Buy
64,929
+4,546
+8% +$185K ﹤0.01% 1366
2022
Q4 		$2.76M Buy
60,383
+544
+0.9% +$23.4K ﹤0.01% 1303
2022
Q3 		$2.91M Buy
59,839
+5,559
+10% +$268K ﹤0.01% 1279
2022
Q2 		$2.34M Buy
54,280
+449
+0.8% +$18.1K ﹤0.01% 1381
2022
Q1 		$1.98M Buy
53,831
+13,846
+35% +$492K ﹤0.01% 1510
2021
Q4 		$1.82K Sell
39,985
-709
-2% -$27.4K ﹤0.01% 1539
2021
Q3 		$1.45M Buy
40,694
+1,941
+5% +$57.1K ﹤0.01% 1624
2021
Q2 		$767K Buy
38,753
+1,009
+3% +$23.7K ﹤0.01% 2143
2021
Q1 		$878K Sell
37,744
-2,286
-6% -$48.8K ﹤0.01% 1966
2020
Q4 		$832K Buy
40,030
+2,280
+6% +$41.7K ﹤0.01% 1928
2020
Q3 		$817K Buy
37,750
+4,199
+13% +$98.2K ﹤0.01% 1753
2020
Q2 		$791K Sell
33,551
-2,649
-7% -$49.7K ﹤0.01% 1729
2020
Q1 		$427K Buy
36,200
+1,959
+6% +$25K ﹤0.01% 1908
2019
Q4 		$363K Sell
34,241
-1,090
-3% -$11.2K ﹤0.01% 2225
2019
Q3 		$403K Hold
35,331
– – ﹤0.01% 2141
2019
Q2 		$397K Buy
35,331
+3,930
+13% +$37.9K ﹤0.01% 2185
2019
Q1 		$255K Buy
31,401
+1,412
+5% +$10.4K ﹤0.01% 2308
2018
Q4 		$189K Sell
29,989
-2,828
-9% -$20.7K ﹤0.01% 2345
2018
Q3 		$323K Sell
32,817
-4,765
-13% -$38.2K ﹤0.01% 2509
2018
Q2 		$313K Buy
37,582
+4,675
+14% +$38.9K ﹤0.01% 2747
2018
Q1 		$237K Sell
32,907
-652
-2% -$5.59K ﹤0.01% 2896
2017
Q4 		$273K Buy
33,559
+944
+3% +$10.7K ﹤0.01% 2776
2017
Q3 		$473K Sell
32,615
-93
-0.3% -$1.27K ﹤0.01% 2312
2017
Q2 		$395K Buy
32,708
+5,490
+20% +$76.3K ﹤0.01% 2476
2017
Q1 		$351K Buy
27,218
+3,042
+13% +$35.6K ﹤0.01% 2429
2016
Q4 		$294K Sell
24,176
-402
-2% -$4.27K ﹤0.01% 2495
2016
Q3 		$225K Sell
24,578
-1,117
-4% -$11.7K ﹤0.01% 2686
2016
Q2 		$244K Buy
25,695
+1,262
+5% +$10.4K ﹤0.01% 2564
2016
Q1 		$164K Sell
24,433
-880
-3% -$6.43K ﹤0.01% 2741
2015
Q4 		$264 Hold
25,313
– – ﹤0.01% 2446
2015
Q3 		$169 Buy
25,313
+765
+3% +$5.22K ﹤0.01% 2782
2015
Q2 		$165 Buy
24,548
+755
+3% +$4.95K ﹤0.01% 3021
2015
Q1 		$161 Sell
23,793
-1,330
-5% -$9.93K ﹤0.01% 2905
2014
Q4 		$201 Buy
25,123
+1,730
+7% +$7.42K ﹤0.01% 2650
2014
Q3 		$82 Hold
23,393
– – ﹤0.01% 3179
2014
Q2 		$111K Buy
23,393
+2,424
+12% +$14.8K ﹤0.01% 3116
2014
Q1 		$199 Sell
20,969
-525
-2% -$4.75K ﹤0.01% 2721
2013
Q4 		$140 Buy
21,494
+2,600
+14% +$17.1K ﹤0.01% 2933
2013
Q3 		$143 Buy
+18,894
New +$203K ﹤0.01% 2889

Other funds holding CYTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s CYTK Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) reduced its Cytokinetics (CYTK) stake by 12% in Q1 2026, selling an estimated $1.51M and leaving 167,124 shares worth $11M. The position accounts for 0.01% of the portfolio, ranked #814.

Manulife (Manufacturers Life Insurance) first reported a position in CYTK in Q3 2013 and has held it in 51 quarters since. The position peaked at $12M in Q4 2025. 439 funds tracked by Wall St. Rank hold CYTK as of Q1 2026.

  • Manulife (Manufacturers Life Insurance) held 167,124 shares of Cytokinetics worth $11M as of Q1 2026.
  • Manulife (Manufacturers Life Insurance) sold 23,683 Cytokinetics shares in Q1 2026, an estimated $1.51M.
  • Cytokinetics made up 0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #814 holding.
  • Manulife (Manufacturers Life Insurance) first reported a position in Cytokinetics in Q3 2013 and has held it in 51 quarters since.
  • Manulife (Manufacturers Life Insurance)'s Cytokinetics position peaked at $12M in Q4 2025.
  • 439 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.